Through our Innovation Seed Fund grants, we aim to pump-prime innovative research into the causes, treatment and diagnosis of hearing loss, tinnitus and other hearing-related conditions.
We want to support novel research ideas with the aim of making them more competitive and able to secure follow-on funding.
The fund will also support small-scale projects at the translational stage, such as proof-of-concept studies or pre-clinical validation studies, again with the aim of making novel approaches more competitive for further funding.
All proposals should be able to demonstrate how they will contribute to ultimately bringing benefit to people with hearing loss, tinnitus or other hearing-related conditions. They should be highly novel and/or innovative – potentially risky ideas are welcome.
Awards are usually made in March each year.
Please note: the Innovation Seed Fund is replacing our Flexi Grant scheme from 2022.
Summary of grant
Closed. The next call for applications will be launched in late 2022.
Up to a maximum of £10,000
Applicants can be from a university, research institute, or small or medium enterprise based anywhere in the world.
In the last round of Flexi Grant funding (March 2021), we received 33 applications and awarded funding to 6 projects.
How to apply
Complete and submit the application form.
Before applying, please read the supporting documents.
- 2022 Innovation Seed Fund call and guidelines
- Guidance for completing the application form
- Innovation Seed Fund standard terms and conditions
All proposals are reviewed by our Innovation Seed Fund review panel (usually three members per proposal). They judge the scientific merit of the proposal, as well as its novelty and feasibility. RNID use these reviews to select the best projects to fund.
Applicants will be notified of the outcome as soon as possible, usually within three months of the application deadline.
Everyone involved in the review process of any grant application is asked to abide by our code of conduct.
Innovation Seed Fund review panel
- Leila Abbas, University of Sheffield
- Roberta Bianco, University College London
- Kali Burke, Johns Hopkins University
- Paige Church, University of Nottingham
- Rebecca Dewey, University of Nottingham
- Soha Garadat, University of Jordan
- Richard Gault, Queen’s University Belfast
- Tobias Goehring, University of Cambridge
- Lauren Hadley, University of Nottingham (Glasgow)
- Emma Kenyon, University of Sussex
- John Newell, Macquarie University
- Sherylanne Newton, MRC Harwell Institute
- Sarah Riutta, Aurora Research Institute
- Joseph Sollini, University of Nottingham
- Jemaine Stacey, University of Nottingham
- Hannah Stewart, University College London
- Haruna Suzuki-Kerr, University of Auckland
- Stephen Terry, University College London
- Samuel Webb, University of Sheffield
- Magdalena Zak, University College London
Europe PubMed Central (Europe PMC) and open access publications
RNID is a member of the Europe PMC Funders’ Group. We support open access publications and require RNID grant holders to make their publications open access.
Read our open access publication policy for more information and visit the Europe PMC website.
If you have any questions or need more information, you can contact us. We’re here to help.